Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000390 · ClinicalTrials.gov registry record · Phase 2
Antidepressant Treatment of AIDS Related Depression.
A Phase 2 study of Depression, sponsored by GEIGY Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00000390: Completed Phase 2 study of Depression, sponsored by GEIGY Pharmaceuticals.
NCT00000390 is a Phase 2 study of Depression that has completed, run by GEIGY Pharmaceuticals. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000390, a Phase 2 study of Depression, has completed, sponsored by GEIGY Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
To test the effectiveness treating AIDS related depression with imipramine hydrochloride. Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentless course of HIV infection, there is a certain reluctance to treat the associated depression. In other illness, it has been proven that treating the depression often results in improvement of overall health status. This is a placebo controlled trial. Half of the patients are given imipramine hydrochloride every day for 6 weeks. Assessment is done by self reports and the Hamilton Depression Rating Scale. Prior to entry all patients are given a psychiatric evaluation. There is a cross over phase in which placebo non responders are entered into an open-label study and given imipramine hydrochloride.
Conditions Studied
Interventions
- DRUG Imipramine hydrochloride
Study Locations (1)
New York
- New York Hosp - Cornell Med Ctr - New York
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000390
The ClinicalTrials.gov registry entry for NCT00000390 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is GEIGY Pharmaceuticals, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Imipramine hydrochloride is the first listed.
NCT00000390 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00000390 about?
NCT00000390 is a clinical study titled "Antidepressant Treatment of AIDS Related Depression.". To test the effectiveness treating AIDS related depression with imipramine hydrochloride. Depression syndromes are commonly associated with chronic, disabling, and fatal diseases. Due to the relentless course of HIV infection, there is a certain reluctance to treat the associated depression. In oth...
What is the current status of trial NCT00000390?
This trial is currently completed. It is a Phase 2 study.
What conditions does trial NCT00000390 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00000390?
The interventions under investigation include: Imipramine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00000390?
This trial is sponsored by GEIGY Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000390 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.